Growth Metrics

BioNexus Gene Lab (BGLC) Shares Issued (2018 - 2024)

BioNexus Gene Lab recorded quarterly Shares Issued of $1064.0 in Q4 2024, down 32.91% quarter-over-quarter from $1586.0 in Q3 2024.

BioNexus Gene Lab's Shares Issued history runs 3 years deep, the most recent figure standing at $1064.0 for Q4 2024.

  • In Q4 2024, Shares Issued changed N/A year-over-year to $1064.0; the TTM figure through Dec 2024 stood at $2650.0 (up 100.53% YoY), while the FY2024 annual figure was $79851.0, changed N/A from the prior year.
  • Shares Issued came in at $1064.0 for Q4 2024 at BioNexus Gene Lab, down from $1586.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $1586.0 in Q3 2024 to a low of $1064.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Linde 230.79 Bn 226.84 Bn 4.26 Bn 3.00 Mn
2 Chemical & Mining Co Of Chile 127.66 Bn 124.93 Bn 778.60 Mn -
3 Sherwin Williams 72.51 Bn 72.30 Bn 2.78 Bn 47.60 Mn
4 Ecolab 70.96 Bn 70.34 Bn 1.85 Bn 46.20 Mn
5 Air Products & Chemicals 62.15 Bn 63.70 Bn 987.40 Mn -
6 Ppg Industries 25.04 Bn 23.57 Bn 1.66 Bn -
7 LyondellBasell Industries 21.62 Bn 21.73 Bn 701.00 Mn -
8 Albemarle 20.26 Bn 19.42 Bn 500.97 Mn 8.92 Mn
9 DuPont de Nemours 19.45 Bn 19.56 Bn 602.00 Mn 84.00 Mn
10 BioNexus Gene Lab 5.34 Mn 1.38 Mn -790.00 -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 1,064.00
Dec 31, 2024 1,064.00
Sep 30, 2024 1,586.00
Sep 30, 2024 1,586.00
Dec 31, 2019 -69,967.00
Dec 31, 2019 -69,967.00
Dec 31, 2018 -429,130.00
Dec 31, 2018 -429,130.00